Stifel Financial Corporation Common Stock (SF)
112.58
-3.13 (-2.71%)
NYSE · Last Trade: Sep 6th, 8:52 AM EDT
The U.S. stock market has delivered surprisingly strong returns in 2025, but history and Wall Street say the index will trade sideways in the remaining months of the year.
Via The Motley Fool · September 6, 2025
Shares of financial services firm Stifel Financial (NYSE:SF) fell 2.6% in the afternoon session after a weaker-than-expected U.S. jobs report sparked broader market concerns about a potential economic downturn. The U.S. Labor Department's report indicated that employers hired fewer workers in August than economists had forecast. Furthermore, previous hiring estimates for June and July were revised downward by a collective 21,000 jobs. This disappointing data follows other recent lackluster economic reports, leading traders to bet on a near-100% probability of a Federal Reserve interest rate cut at its next meeting. The broader market slipped as investors grappled with whether the job market has slowed just enough to warrant a rate cut or so much that it signals an impending economic downturn.
Via StockStory · September 5, 2025
Via Benzinga · September 1, 2025
A piece of financial engineering, plus an analyst's price-target cut, put the brakes on the stock.
Via The Motley Fool · August 29, 2025
Via The Motley Fool · August 29, 2025
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested that with inflation risks moderating and unemployment remaining low, the Federal Reserve might consider a shift in its monetary policy stance, including potential interest rate cuts. This outlook eased market concerns about prolonged high interest rates and their impact on economic growth. The prospect of lower borrowing costs bolstered investor confidence, particularly in sectors that have lagged, leading to a broad rally across the market.
Via StockStory · August 22, 2025
Ionis Pharmaceuticals rose 2.38% after hours following a planned stock sale by its chief scientific officer under a Rule 10b5-1 plan.
Via Benzinga · August 21, 2025
The company continued its forward momentum after last week's well-received earnings release.
Via The Motley Fool · August 15, 2025
Via Benzinga · August 3, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 31, 2025
Via Benzinga · July 30, 2025
Stifel Financial reports mixed Q2 2025 earnings, beating revenue and EPS estimates but shares dip on lower GAAP profitability and lack of guidance.
Via Chartmill · July 30, 2025
Kratos Defense is capitalizing on the military's shift to autonomous warfare with key program wins for its Valkyrie drone and new production capacity.
Via MarketBeat · July 24, 2025